Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Dose-comparison for Acute Migraine
NCT04112823Phase 4Completed
- Sponsor
- Montefiore Medical Center
- Start
- Dec 2019
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of dexamethasone in migraine (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Number of Subjects With Headaches Who Have Sustained Headache Relief for 48 Hours. Started Dec 2019; status: completed.
02
Drugs
dexamethasone
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04112823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04112823.